Dihydrostreptomycin

An antibiotic used in the treatment of tuberculosis and other bacterial infections

Dihydrostreptomycin

Chemical structure of Dihydrostreptomycin

Dihydrostreptomycin is an aminoglycoside antibiotic derived from streptomycin. It is primarily used in the treatment of tuberculosis and other bacterial infections. Dihydrostreptomycin works by inhibiting protein synthesis in bacteria, leading to cell death.

Mechanism of Action

Dihydrostreptomycin binds to the 30S subunit of the bacterial ribosome, interfering with the initiation complex and causing misreading of mRNA. This action inhibits protein synthesis, which is essential for bacterial growth and replication. The bactericidal effect of dihydrostreptomycin is concentration-dependent.

Clinical Uses

Dihydrostreptomycin is used in combination with other antibiotics to treat Mycobacterium tuberculosis infections. It is also effective against a variety of Gram-negative bacteria, including some strains of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Side Effects

The use of dihydrostreptomycin can lead to several side effects, the most significant being ototoxicity and nephrotoxicity. Ototoxicity can result in irreversible hearing loss, while nephrotoxicity can cause kidney damage. Patients receiving dihydrostreptomycin should be monitored for signs of these adverse effects.

Resistance

Bacterial resistance to dihydrostreptomycin can occur through various mechanisms, including the modification of the antibiotic target site, enzymatic inactivation, and efflux pump activation. Resistance is a significant concern in the treatment of tuberculosis, necessitating the use of combination therapy to prevent the development of resistant strains.

History

Dihydrostreptomycin was developed as a derivative of streptomycin to improve its pharmacological properties. It was first introduced in the 1940s and has since been used in the treatment of various bacterial infections. However, due to its side effects and the development of resistance, its use has declined in favor of newer antibiotics.

Related pages

• Streptomycin
• Aminoglycoside
• Antibiotic resistance
• Tuberculosis treatment